Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

33.66 +0.09 (+0.28%)
Streaming Delayed Price Updated: 12:52 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Why Omnicell Stock Crushed the Market Today
The company continues to benefit from demand for its next-generation healthcare tech offerings. 
Via The Motley Fool
Why Omnicell (OMCL) Stock Is Trading Up Today
Shares of healthcare tech company Omnicell (NASDAQ:OMCL) jumped 10.9% in the morning session after the company reported strong third-quarter 2025 financial results that beat expectations and raised its... 
Via StockStory
Topics Economy Government World Trade
Omnicell Inc (NASDAQ:OMCL) Surpasses Q3 2025 Estimates, Stock Rises on Strong Guidance
Omnicell (OMCL) Q3 2025 earnings beat estimates, with revenue of $310.6M and non-GAAP EPS of $0.51. The stock rose 8% pre-market on the strong results and raised guidance. 
Via Chartmill
Topics Earnings
Earnings Scheduled For October 30, 2025
 
Via Benzinga
Analyst Expectations For Omnicell's Future
 
Via Benzinga
Earnings Scheduled For July 31, 2025
 
Via Benzinga
Omnicell (NASDAQ:OMCL) Reports Bullish Q3, Stock Soars
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 10% year on year to $310.6 million. On top of that, next quarter’s... 
Via StockStory
Omnicell Announces Third Quarter 2025 Financial Results
From Omnicell, Inc.
Via Business Wire
Omnicell (OMCL) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday morning. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
3 of Wall Street’s Favorite Stocks That Concern Us
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Healthcare Technology Stocks Q2 Highlights: Tandem Diabetes (NASDAQ:TNDM)
Looking back on healthcare technology stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Tandem Diabetes (NASDAQ:TNDM) and its peers. 
Via StockStory
Q2 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology for providers stocks fared in Q2,... 
Via StockStory
Q2 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Premier (NASDAQ:PINC) and its peers. 
Via StockStory
Topics Economy
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025
From Omnicell, Inc.
Via Business Wire
1 Stock Under $50 with Promising Prospects and 2 Facing Challenges
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
3 Cash-Producing Stocks We Keep Off Our Radar
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
3 Cash-Heavy Stocks We Approach with Caution
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
3 Low-Volatility Stocks We Steer Clear Of
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
Topics Retirement
Q2 Earnings Highlights: Omnicell (NASDAQ:OMCL) Vs The Rest Of The Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Omnicell (NASDAQ:OMCL) and its peers. 
Via StockStory
Omnicell Appoints Baird Radford as Executive Vice President and Chief Financial Officer
From Omnicell, Inc.
Via Business Wire
2 Profitable Stocks Worth Investigating and 1 Facing Challenges
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
OMCL Q2 Deep Dive: Product Innovation and Recurring Revenue Drive Upbeat Guidance
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 5% year on year to $290.6 million. On top of that, next quarter’s... 
Via StockStory
Topics World Trade
Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Stocks
1 Small-Cap Stock for Long-Term Investors and 2 We Avoid
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Omnicell (NASDAQ:OMCL) Reports Upbeat Q2, Full-Year Outlook Slightly Exceeds Expectations
Healthcare tech company Omnicell (NASDAQ:OMCL) announced better-than-expected revenue in Q2 CY2025, with sales up 5% year on year to $290.6 million. On top of that, next quarter’s revenue guidance... 
Via StockStory
Omnicell Announces Second Quarter 2025 Results
From Omnicell, Inc.
Via Business Wire
Earnings To Watch: Omnicell (OMCL) Reports Q2 Results Tomorrow
Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday before market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
3 Healthcare Stocks We Approach with Caution
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
Why Omnicell (OMCL) Stock Is Trading Up Today
Shares of healthcare tech company Omnicell (NASDAQ:OMCL) jumped 3.3% in the afternoon session after an analyst at Wells Fargo raised the firm's price target on the stock and maintained an "Overweight"... 
Via StockStory
Topics ETFs Stocks World Trade
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.